Volume 15, Number 2—February 2009
Research
Methicillin-Susceptible Staphylococcus aureus in Skin and Soft Tissue Infections, Northern Italy
Marco Tinelli, Monica Monaco, Maurizio Vimercati, Antonio Ceraminiello, and Annalisa Pantosti
Table 1
Characteristics of patients with community-acquired MSSA skin and soft tissue infections, their treatment, and molecular typing of the isolates, northern Italy, 2004–2006*
| Patient | Age, sex | Site of infection† | Type of infection† | Antimicrobial drug treatment† | Drainage | Molecular typing of MSSA isolates |
|||
|---|---|---|---|---|---|---|---|---|---|
| Presence of PVL genes | PFGE type | spa type | ST | ||||||
| Family clusters | |||||||||
| Cluster 1 | |||||||||
| P 1 | 32 y, F | Leg | Abscess | None | Spontaneous | NA | |||
| P 2 | 33 y, M | Axilla | Abscesses | AMC, CIP | None | NA | |||
| P 3 | 4 d, M | Prepuce | Pustules | GEN | None | NA | |||
| Cluster 2 | |||||||||
| P 4 | 30 y, F | Vulva, thighs | Pustules, abscesses | AMC, LFX, TEC | None | + | A | t005 | 22 |
| P 5 | 33 y, M | Nose, scalp | Pustules | AMC | None | NA | |||
| P 6 | 14 mo, F | Thigh | Pustules | CLI | None | NA | |||
| P 7 | 14 d, F | Thigh | Pustules | CLI | None | + | A | t005 | ND |
| Cluster 3 | |||||||||
| P 8 | 32 y, F | Face, vulva, leg | Abscesses | AMC, CIP, LFX | None | + | A | t005 | 22 |
| P 9 | 25 mo, F | Leg | Abscess | None | Spontaneous | NA | |||
| Cluster 4 | |||||||||
| P 10 | 34 y, F | Axilla, forearm, leg | Abscesses | AMC | None | NA | |||
| P 11 | 35 y, M | Axilla, forearm, leg | Abscess, furuncles | AMC, LFX | Surgical | + | A | t005 | ND |
| P 12 | 4 d, M | Neck, groin, axilla, | Pustules, abscesses | AMC, AMC | Spontaneous | + | A | t005 | 22 |
| P 13 | 3 y, M | Forearm | Abscesses | AMC | None | NA | |||
| P 14 | 65 y, F | Axilla, forearm, leg, face | Abscess | None | None | NA | |||
| Cluster 5 | |||||||||
| P 15 | 33 y, F | Face, leg, axilla | Pustules, abscess | AMC | Surgical | NA | |||
| P 16 |
36 y, M |
Thigh |
Furuncles, abscess |
AMC |
None |
NA |
|||
| Sporadic cases | |||||||||
| P 17 | 64 y, F | Axilla | Abscess | CIP | None | + | A | t005 | 22 |
| P 18 | 7 mo, F | Arm | Pustules | AMC | None | – | F | t159 | ND |
| P 19 | 9 y, F | Axilla | Furuncles | AMC | None | – | F | t159 | ND |
| P 20 | 12 mo, M | Groin | Abscess | AMC | None | + | A | t005 | ND |
| P 21 | 8 y, F | Leg | Abscess | AMC | None | – | G | t445 | ND |
| P 22 | 18 mo, M | Forearm | Furuncles | AMC | None | + | A | t005 | ND |
| P 23 | 12 mo, F | Buttock | Abscess | AMC | Spontaneous | + | A | t005 | ND |
| P 24 | 20 mo, F | Thigh | Abscess | AMC | None | + | A | t005 | 22 |
| P 25 | 8 y, M | Arm, chest | Abscesses | AMC | Surgical | + | A | t005 | ND |
| P 26 | 11 y, M | Face, eye | Abscess, conjunctivitis | AMC | None | + | A | t005 | 22 |
*MSSA, methicillin-susceptible Staphylococcus aureus; PVL, Panton-Valentine leukocidin; PFGE, pulsed-field gel electrophoresis; ST, sequence type; NA, isolate not available; AMC, amoxicillin-clavulanic acid; CIP, ciprofloxacin; GEN, gentamicin (topical); LFX, levofloxacin; TEC, teicoplanin; CLI, clindamycin (topical); ND, not determined.
†When >1 site or type of infection or antibimicrobial agents are indicated, they refer to different infection episodes.
Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.